ArticleChem & bio engineering2026
Biocatalytic Arene Functionalization Using Integrated Unspecific Peroxygenase and Halohydrin Dehalogenase.
Article in Chem & bio engineering, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In pharmaceuticals, aromatic structures are common motifs, underscoring the need for efficient and sustainable functionalization of arene compounds, particularly in late-stage functionalization. This study introduces a biocatalytic cascade employing unspecific peroxygenases (UPOs; PaDa-I mutant) and halohydrin dehalogenases (HHDHs), performed under batch conditions as a proof of concept. Significant advancements were achieved in the design of our microfluidic devices, where we incorporated HPLC screw fittings to minimize leakage and enhance compatibility with conventional flow equipment. To immobilize PaDa-I, we explored three covalent methods: (i) poly dopamine (PDA) surface coating, (ii) PDA with copolymerized polyethylenimine, and (iii) carbodiimide cross-linking. Among these, carbodiimide cross-linking achieved the highest activity yield (27%) under continuous-flow conditions, representing the most efficient immobilization reported to date for PaDa-I. To circumvent UPO instability toward hydrogen peroxide, we substituted it with ascorbic acid (AscA) for the epoxidation of styrene derivatives, improving PaDa-I stability to 6 days, achieving a yield of 37%, and maintaining productivity of 17 μM/h. Using EMIN340 and EMIN510 mutants from the commercial HHDH kit of Enzymaster facilitated the conversion of styrene oxide to
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.